Avalo Therapeutics (AVTX) Gross Margin (QoQ) (2017 - 2023)
Powered by 
Analysis
Avalo Therapeutics (AVTX) Gross Margin (QoQ) (2017 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Avalo Therapeutics | 835.85 Mn | 835.85 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 14,337.00 |
| Sep 30, 2023 | 545.00 |
| Jun 30, 2023 | 589.00 |
| Mar 31, 2023 | -4,680.00 |
| Dec 31, 2022 | -6,566.00 |
| Sep 30, 2022 | 14,816.00 |
| Jun 30, 2022 | -9,031.00 |
| Mar 31, 2022 | 13,223.00 |
| Dec 31, 2021 | -12,635.00 |
| Sep 30, 2021 | -6,479.00 |
| Jun 30, 2021 | 1,381.00 |
| Mar 31, 2021 | -1,100.00 |
| Dec 31, 2020 | 165.00 |
| Sep 30, 2020 | -110.00 |
| Jun 30, 2020 | -343.00 |
| Mar 31, 2020 | -46,289.00 |
| Dec 31, 2019 | 46,651.00 |
| Sep 30, 2019 | 10,089.00 |
| Jun 30, 2019 | -7,796.00 |
| Mar 31, 2019 | 490.00 |